First Capital Advisors Group, Llc. Vertex Pharmaceuticals Inc Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 748 shares of VRTX stock, worth $370,454. This represents 0.14% of its overall portfolio holdings.
Number of Shares
748
Previous 674
10.98%
Holding current value
$370,454
Previous $212,000
24.06%
% of portfolio
0.14%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,651Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.7 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.9 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.95 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.51 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $127B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...